Topically applied medications are a cornerstone of the field-directed treatment of actinic keratoses. In photodynamic therapy, a topical agent is combined with a procedural method. In cases of insufficient response, severe hyperkeratosis or in high-risk patients, other combined therapy strategies can also be considered, such as lesion-directed destruction of individual lesions followed by field-directed therapy. Immunocompromised patients have an increased risk of progression from AK lesions to cutaneous squamous cell carcinoma.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- T-cell lymphomas
Diagnostic Challenges and New Treatment Options
- Interbrain Synchrony
Two Brains, One Thought
- Atopic Dermatitis in Children and Adults
Topically Applied “Small Molecules”: Janus Kinases or PDE-4 as Targets?
- Dermatomyositis
Glucocorticoids for more than one year
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Diabetic Polyneuropathy
Clinical Presentation, Diagnosis, and Treatment of DSPN
- From symptom to diagnosis
Pulmonology – Lobus venae acygos
- Atopic Dermatitis: Precisely Targeting Immunological Targets